Revenue Growth and Increased EPS
The September quarter revenues were $240 million, a 7% increase from the $224 million in the September 2024 quarter. The earnings per share for the quarter ending September 30, 2025, were $0.54, marking a 20% increase over the previous year's EPS of $0.45.
AI Integration and Technological Advancements
CorVel is leveraging Agentic AI to enhance productivity, reduce costs, and accelerate decision-making. AI-driven enhancements have improved capacity and precision in identifying medical bills and claims with potential savings.
Strong Financial Management
CorVel reported improved gross margin and net income, reaching $28 million, up from $23 million in the previous year. The company repurchased 143,774 shares at a cost of $12.8 million, maintaining a strong and debt-free balance sheet with a cash balance of $207 million.
Organic Growth and Operational Efficiency
The company reported significant organic growth, driven by expanded activity with existing partners. Network Solutions increased by $12 million, primarily reflecting higher utilization of CERiS, Ancillary Care, and Bill Review Solutions.